The 2nd International Electronic Conference on Vaccines

University of Texas Health Science Center’s Institute of Molecular Medicine (IMM) , USA;
Prof. Eva M. Sevick, Ph.D. is At the IMM she leads the National Cancer Institute Center for Translational Research which focuses upon the development and validation of new imaging instrumentation, algorithms, and imaging agents and their clinical translation. She has pioneered the development of near-infrared fluorescence optical imaging and tomography for molecular imaging and currently has two clinical trials underway at the University of Texas Health Science Center and Memorial Hermann Hospital that employ the technology for novel diagnostic imaging of lymphatic function. Her team is active in preclinical, small animal imaging with nuclear and optical techniques and is pioneering diagnostic imaging for nodal staging in cancer. Dr. Sevick received her Ph.D. in Chemical Engineering at Carnegie Mellon University with Rakesh Jain, her post-doctoral training in Biochemistry and Biophysics at the University of Pennsylvania with Britton Chance, and has served on the faculties at Vanderbilt, Purdue, Texas A&M as well as Baylor College of Medicine. She is past recipient of the National Science Foundation Young Investigator Award, the National Institutes of Health Research Career Award, and the American Cancer Society Research Scholar Award and has served as an appointed member of the Biomedical Imaging Study section, associate editor of the IEEE Transactions of Medical Imaging, and officer of the Society of Molecular Imaging.

1. Department of Immunology, University of Bern, Bern, Switzerland, 2. Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK;
Martin Bachmann studied Cell Biology at the ETH Zürich. In 1995, he earned his PhD Immunology from the ETH Zürich in Switzerland under the supervision of Prof. Zinkernagel in Zürich followed by a Post-Doc at the laboratory of Prof. Ohashi in Canada. After working as a member at the Basel Institute for Immunology and running research at a Biotech company for 10 years, Martin Bachmann became a faculty member and full professor at the University of Bern. Martin is currently professor at the University of Bern and University of Oxford.

Erasmus MC, Rotterdam, Netherlands;

Interdisciplinary Department of Medicine, University of Study of Bari, Bari, Italy;

Principal Investigator Collaborative Anti-Viral Research group (CAVR), Institute of Molecular and Cell Biology (IMCB), Proteos, Singapore;